Bisphenol A in our food : same toxicological studies but different risk assessment and risk management decisions around the world. by Scippo, Marie-Louise
Bisphenot A in our food: sârnê toxicotogicat
studies but different risk assessment and risk
management decisions around the world
Marie-Louise Scippo, Department of Food Sciences, Faculty of veterinary medicine, University of Liège, Belgium
INTRODUCTION
BisphenoI A tBPA] [2,2-bis-(4-hydroxy-
phenytl propane, CAS no 80-05-71 [figure
'il is an industriat chemicaI compound
synthesized from the condensation of two
phenot groups and one acetone molecute
[the A in bispheno[ A stands for acetone).
Other synonyms for bisphenoI A are
L,4' -dihydroxy-2,2-diphenytpropane loff i-
ciat IUPAC nomenctaturel, 4,4'-{propan-
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2-ytidenel diphenot, p, p'-isopropytidene-
bisphenoI or 4,4'-isopropytidenediphe-
no[-
It is used as a monomer in the manufac-
turing of potymers such as polycarbonate
lfigure 2] and the epoxy resins lfigure 3],
as wett as antioxidant and inhibiter of end
ol potymerization in potyvrnyl ch[oride
ptastics {PVCI. The potycarbonate is used
in materia[s intended to come into contact
with food, [ike certain reusabte ptastic
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bottles, feeding botttes, plates, gobtets,
cups, etc., white the epoxy resins are used
in the internaI coating of cans. However,
onty 3 % of at[ the potycarbonate produced
as well as 10 0/o of the epoxy resins are
used in materiats intended to come into
contact with foodstuffs (Ptastics Europe,
20071. The other uses are sun gtasses,
buitding materials, CD-R0M, medicat de-
vices, etc.
5âmenvâtting
Bisphenot A [BPAI [2,2-bis-t4-hydroxyphenytlpropaan. CAS n" 80-05-7] is een industriëte chemische stof, gesyntheti-
seerd uit de condensatie van twee fenotgroepen en één aceton motecu[e [de A in bisphenot A staat voor aceton). Andere
synoniemen voor bisphenot A zijn 1+,4'-dihydroxy-2,2-diphenytpropane {officieet IUPAC-nomenclatuur}, 4,4'-[propan-2-
ytidenel difenot, p, p'-isopropytidenebispheno[, of4,4'-isopropytidenediphenot.
Het wordt gebruikt ats een monomeer bij de productie van potymeren zoals polycarbonaat en de epoxyharsen, atsook
ats antioxidant en polymerisatie-inhibitor binnen potyvinytchtoride IPVC]. Het polycarbonaat wordt gebruikt in mate-
riaten die bedoetd zijn om in contact te komen met voeding, zoats bepaalde herbruikbare ptastic flessen, zuigf[essen,
borden, drinkbekers, kopjes, enz. terwijI de epoxyharsen gebruikt worden ats dektagen van voedse[- en drankblik.jes.
Niettemin wordt stechts 3 o/o van alte geproduceerde potycarbonaat en 10 o/o van de epoxyharsen gebruikt in materiaten
die bedoeld zijn om in contact te komen met levensmiddelen lPlastics Europe, 2007]. Andere toepassingen zijn zonne-
britten, bouwmaterialen, cd's, medische hulpmiddeten, enz.
Résumé
Le bisphénol A IBPAI [2,2-bis-[4-hydroxyphényUpropane, CAS n' 80-05-71 est un composé chimique industriel issu
de [a condensation de deux groupes de phénot et une motécule d'acétone lte A de bisphénot A réfère à ['acétone].
D'autres synonymes pour [e bisphénol A sont 4,4'-dihydroxy-2,2-diphénytpropane {nomenclature officielte IUPAC],
4.4'-tpropan-2-ytidène)diphénot, p, p'-isopropytidènebisphénot, ou 4,4'-isopropytidènediphéno[.
Le bisphénot A est utitisé comme monomère pour [a fabrication de potymères tets que [e potycarbonate et tes résines
époxy, comme antioxydant et comme inhibiteur de po[ymérisation dans [e potychtorure de vinyte [PVC]. Le potycarbo-
nate est utitisé dans tes matériaux qui entrent en contact avec les denrées alimentaires, comme certaines bouteilles
en ptastique réutitisabtes, des biberons, des assiettes, des gobetets, des tasses etc., tandis que les résines époxy sont
utitisées comme revêtement intérieur des boîtes de conserves.
Tout de même, ce n'est que 3 o/o de [a production totate du potycarbonate et 10 % des résines époxy qui sont utitisés
dans des matériaux destinés à entrer en contact âvec tes denrées alimentaires IPtastics Europe, 2007]. D'autres appti-






Figure l: chemica[ structure of bispheno[ A










A kind of controversy exists since 2008
about the good decision to take about
bisphenot A in baby feeding botttes. Ca-
nada and some states of the USA banish it
since 2008, while in the European Union,
the decision has just been taken lEuro-
pean Commision, 2011) and witl enter
in force on 1 "i March 201 1, for the ban of
manufacture of feeding bottles containing
BPA, and on 1" June 2011, for the ban
of ptacing on the market feeding botttes
containing BPA.
This kind of decision is a part of the risk
management process, which has to be
conducted by pubtic authorities.
The previous step beforê risk manage-
ment is risk assessment, which is a scien-
tific evatuation. Risk assessment is based
on toxicotogica[ studies, as welt as expo-
sure studies, in the aim to assess the risk,
for the consumer, [inked to the ingestion
of the substance of interest via food.
Here betow are presented the risk as-
sessment studies performed for BPA in
various countries untit now.
It witL be shown that different risk as-
sessment conclusions and different risk
manâgement decisions resuttèd from the
evaluation of the same toxicotogicat stu-
dies published in the literature.
0pinion on BPA oî the Scientific committêe
on Food ISCFI and the European food sa-
fetyauthoriÿ IEFSAI
The toxic effects of BPA were eva[uated for
the first time in 1984 by the SCF lScienti-
fic committee on food - SCF, 1986), which





of 0.05 mg/kg of body weight, on the ba-
sis of chronic oral exposure studies {?0
days) carried out in rats and mice. A "no
adverse effect levet" (NOAEL) of 25 mg/
kg body weightlday was found, related to
a reduction in the body weight of the ani-
mats, to which a factor of uncertainty of
500 had been apptied because of incom-
plete data.
The risks for heatth retâted to the BPA
were then re-evatuated in 2002 by the SCF
which established this time â provisionâl
TDI of 0.01 mg/kg body weight, on the
basis of studies carried out in rats [oral
exposure during 90 days, study on 3 ge-
nerations). The N0AEL, stitt retated to the
body weight, was of 5 mg/kg boy weight/
day ICSAH, 2002].
ln 2006, the EFSA estabtished a TDI for
BPA of 0.05 mg/kg body weight, on the
basis of an unchanged NOAEL, compared
to the preceding opinion, of 5 mg/kg body
weight/day, but to which a factor of uncer-
tainty of 100 instead of 500 was apptied,
because the databases were more com-
plete than in 2002 {EFSA, 2006).
ln 2008, the EFSA pubtished an opinion on
the toxicokinetics of BPA and confirmed
the TDI of 0.05 mg/kg body weight. The
opinion stated that the differences in toxi-
cokinetics according to the age between
animals and humans did not justify io
increase the factor of uncertainty, on the
basis that newborns woutd be abte to me-
tabotize BPA [this deduction came from















Figure 3: chemical structure of an epoxy resin
It is wett known that chemicaI substances
can be reteased from ptastic materiats
and articles intended to come into contact
with food, and [imits of migration are
mentioned in the European Legistation for
a[t permitted substances in such plastic
materiats. At the momeni, the [egistation
still in force is the Directive 200217218C
IEC, 2002], transposed in Betgium in the
Royat Decree of 3 Juty 2005 which witt be
reptaced, on 1't May 201 1, by the Reguta-
tion [EU) N'10/2011 tEU.2011]. For BPA,
a specific [rmit of migration [SLM) is fixed
since 2004 to 0.6 mg/kg food product, and
is not changed in the new regulation.
BPA is described as an endocrine disrup-
tor because many studies showed that it
has estrogenic properties. lt is in parti-
cular able to bind and activate the human
estrogen receptor but, with a capacity
1,000 to 5,000 times less than the endo-
genous 178-oestradiot, the naturaI tigand
of this receptor IFASFC, 2009].
BPA is ctassified as a substance repro-
poison of category 3 la[arming substance
for the ferti[ity of the mankind - INSERM,
20 1 0).
Because of that characteristic, the BPA
has a very bad reputation. BPA was very
often cited in the media these last months,
mainty about potycarbonate baby feeding
botttes, which can retease BPA when their
content is heated lwhich correspond to a
normal use of these botttes] however the
amounts released are far [ower than the
SLM {De Coensel et al., 2009J. The conse-
quence of this retease is the exposure of
the baby to an endocrine disrupting che-
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Very recentty, on September 30th, 2010,
the EFSA published its most recent opi-
nion based on an evatuation which had
been carried with 3 distinct objectives:
1J to evatuate the studY Pubtished
by Stump and co-workers in 2009'
concerning the devetoPmentaI
neurotoxicity of BPA in the rat;
2) to re-examine the reLent scientific
literature, in order to re-evatuate
the risk related to BPA and the de-
termination of its TDI;
3) to give an opinion on the risk eva-
tuation reatized bÿ the nationaI
food institute, TechnicaI University
of Denmark IDTU, æ10] and to try
to substantiate tlç subsequent
banishment, in Derlmark. of BPA
in the feeding bott[es.
With regard to item '1, fottowing an etabo-
rate statistical expertise {EFSA. 2010}, the
ËFSA conctuded that the study of Stump
and co-workers [2009] does atLow to draw
conclusions. 
i
With regard to item 2, the foltowing
conctusions were emitted: I
- the studies of the toxicokinetics o{ BPA
showed that BPA was etifninated more
quickty in the primates than in the ro-
dents. The premature children are able
to metabolize and excrete tsPA efficientiy.
The same conclusion is atLo emitted for
the "s[ow metabolisers" [i:eopte among
whom the isoenzymes of Fletabotisation
are less activel. :
- the exposure of the fetus ln utero and the
infant nursed by his mother seems [imi-
ted.
- recent epidemiotogical §tudies having
shown a link between the 
€rxposure to the
BPA lestimated on the basis of urinary
concentration) and effects on the adutt
heatth Ion the cardiovascutar system
and the reproductive apparatus) and on
the behaviour of young girts, cannot be
taken into account in the risk evaluation,
because of weaknesses in these studies.
- the studies of the toxic effects of low
doses of BPA [. NOAELI on development
and reproduction, carried out in rats, can-
not be regarded as vatid.
- according to a study on the sexuaI beha-
viour of femates rats, the BPA in viro does
not seem to have an estrogenic effect
(contrary to the rats treated with estro-
gens used as positive controtsJ.
- two recent studies indicate that the BPA,
fotlowing an exposure during Iactation
[Jenkins et a{.. 2009] or in ufero lBetan-
court et at., 20101, woutd increase the
sensitivity of mammary gtand to devetop
cancer, after exposure to carcinogenic
substances. The two studies present [imi-
tations and cannot be taken into account
but the EFSA indicates that the potential
effects announced shou[d be further stu-
died.
- severaI studies showed effects of BPA
on the immune system, but they cannot
be validated because of experimental [i-
mitations.
- several in vitro and ln vivo studies [but
not corresponding to the criteria setec-
ted by the panel of experts of EFSA to
be taken into account in the risk eva[ua-
I fooascience&Law2o1l-Os.indd 1t
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tionl showed modifications Irncluding low
doses) on the [eve[ of receptors, on the
immune system, the ce[ protiferation, the
apoptose, and at a genomic and epigene-
tic tevet. These modifications are in reta-
tion to the potential endocrine disturbing
effect of BPA. These studies present [imi-
tations and it is difficutt to deduce a ctear
mode of action at low doses as we[[ as an
effect on the human health.
With regard to the third point, the DTU in
Denmark had advanced three arguments
IDTU,2010]:
- the uncertainty retated to the effect of
BPA on the capacity of learning Istudy of
Stump et al., 20091;
- the existence of a doubt about the mo-
notonous propriety of the dose-response
curve of the BPA [which does not take into
account the effects at low doses];
- certain effects were not studied: trai-
ning and memory, anxious behaviour and
gender-specif ic behaviour lsexuaI dimor-
phisml.
For the reasons mentioned above Iconcer-
ning the first 2 pointsl, the EFSA did not
regard the arguments advanced by the
OTU as retevant.
This opinron of the EFSA {EFSA, 20 1 0} atso
mentions a minority opinion of an expert
from the CEF panel {panet on food contact
materiats, enzymes, f[avourings and pro-
cessing aidsl who wished to mark its dis-
sension with the conctusions of the maio-
rity of the other experts published in the
opinion on BPA IEFSA, 201 0] and to inform
of its concern with respect to the possibte
effect of BPA on the human heatth, taking
into account of some uncertainties in re-
centty pubtished toxicologicaI studies.
ùpinion on BPA of the ANSES, the lormer
EFSA (French Agency for Food, Environ-
mental and Ùccupational Health & Safetyl
The ANSES pubtished on opinion, on 0c-
tober 20th, 2009, in the aim to answer
three questions;
1 ] Does the study of the toxicity of BPA on
the nervous system development [Ame-
rican Chemistry Counci[, 2009], carried
out according to guidetine n" 426 of the
Organization for Economic Co-operation
and Devetopment (OECDI, show negative
effects of BPA on the offspring consecu-
tive to BPA exposure during gestation and
breast-feedi ng?
The experts estimate that this study does
not show any neurotoxic effect in the offs-
pring of mothers treated with doses of BPA
corresponding to the N1AEL. But at higher
doses, the study does not altow to draw
conclusions, taking into account the ab'
sence of investigation on the origin of the
convu[sions observed in same rats.
2) Does this study at[ow to assess the
lack of toxicity of the BPA at tow doses,
on the neurologicaI and behaviouraI de-
vetopment? Do the recent literature data
confirm atarming effects in terms of pu-
btic health, after exposure to very low
doses of BPA? Do these data resutt in mo-
difying the toxicotogical reTerence dose
retained to estabtish the TDI?
ln the studies of the literature, the effects
observed with very low doses of BPA cor-
respond ta subtte functional modifications
{ne,urological, hormonal or metabolicl and
are to be interpreted as warning signal be-
cause their fatal consequences for the hu-
man heatth are not established. However,
these studles display important methodo-
togicaL blas and do not aLlow to establish a
dose-response retatianship nor to define a
toxicotogicaL dose of reference to establlsh
a newTDt. ln the current position of knowle-
dge, it is not possible to correlate the data
of exposure recorded in humans with the
effects observed in vivo in animals, because
of i nsuf f ici e nt t oxico k i netics data.
3) ln a more general way, is the metho-
dotogy of risk evatuation based on the
concept of the TDI wetl adapted to endo-
crine disruptors, such as BPA?
The TDI corresponds to the maximum quan'
tity of a contaminant which can be consu'
med daity during the whole life without
harmfut effects for the human heatth. ln the
case of endocrine disruptors compounds,
being able to exert different effecB accor-
ding to the stage of development {critical
windows of exposure during which harmfuL
effects can appear, in particuLar the pre-
natal period), the TDI does not appear to
be the best approach for risk eva[uation. ln
addition, the guideline no 426 of 1ECD does
not appear entirely adapted to characterize
subtle eflects on the nervous system, such
as they could be observed with endocrine
disruptors and in particular with BPA.
ln its oprnion, the ANSES indicates the
presence of warning signa[s observed tn
in vitro and m vivo studies, with âmounts
tower than the NOAEL [5 mg/kg Pc/day),
whose significance should be determined.
The ANSES recommends to use the prtn-
ciple of the M0E [Margin 0f Exposure] to
evatuate the risk retated to the exposure
to BPA, but for that, it would be neces-
sary to determine the significance of the
warning signats and to possibly re-exa-
mine the toxicological dose of reference
IANSES,20lO}.
ùpinion on BPA of the German federal ins'
tituta tor risk assessment: BîR (Bunde-
sin stitut f ü r Ri si kobewertu ng I
0n Juty 29th, 2010, BfR published an opi-
nion concerning the studies of Stump and
collaborators [2009] and of Ryan et al.
(20 1 0). The purpose of the study of Stump
et al. was to measure thê neurotoxicity of
the BPA and its effects on the behaviour in
rats, after exposure to various amounts,
inctuding tow doses- The study of Ryân
and co-workers aimed to measure the
oestrogenic effects in the offspring of fe-
male rats whose mothers had been trea-
ted with BPA during gestation and lacta-
tion.
According to BfR, none of the two studies
brings substantiaI proof of a specific toxic





The conclusion of the BfR is in agreement
with that of EFSA, who atso invalidated
the study of Stump ef al., fotlowing a tho-
rough statistical anatysis which showed
weaknesses in the experimental design
{EFSA. 2010}. With regard to thë study of
Ryan et ai., the EFSA concluded that the
study was vatid and that it did not show
any effect of low doses of BPA on the de-
velopment of an abnormat sexual beha-
viour in female rats.
0pinion on BPA of Hêalth Canada
ln 2008, Heatth Canada published a risk
evaluation about the neurobehaviorat toxi-
city of BPA. Heatth Canada conctuded that
evidences of the neurotoxicity of the BPA
were timited. On the websitè of Heatth
Canada it can be found that ["Heatth Ca-
nada's Food Diràcroràte has concludêd that
the current dietàr,y exposure to BPA through
food packaging uses is not expected to pose
a heatth risk to the general population, in-
cLuding newborrs and infants". However,
by measure of precaution and to timit the
exposure of the infants Iapptication of the
principle of exposure -ALARA" - As Low
As Reasonabty Achievabte), the Canadian
government prohibited the use of potycar-
bonate for the manufacturing of feeding
bottles {coming into effect of this prohibi-
tion on March 11th.2010].
Opinion on BPA of the 
^ratioral 
Japanese
institute of AdÿAnced lndustrial Science
and Technology lAlSTl
ln 20û5, the AlSTprbtished a risk evalua-
tion of the BPAbn human heatth, on the
basis of the toxicotogical profite of the
BPA leffects on the body weight, the tiver
and reprotoxicityl and on estimates of the
human exposure.
For the 3 types of effects observed, the
NOAEL or BenchMark Dose Limit IBMDL]
varied from 5 to 50 mg/kg PC/day, with a
MOE from 85,0û0 to 1,800,000. ln an ex-
treme scenario lworst case), the M0E was
> 1,000. The AIST thus conctuded that the
levels of exposure to BPA did not pose
an unacceptable heatth risk for human
heatth.
opinion on BPA of the National Toxicology
Program - Center lor thê Eveluation of
Risks to Human Reproduction NfP - CE-
RHN IUSAI
The NTP indicates that the possib[e ef-
fects of BPA on the brain, the behaviour
and the prostate in the foetus, the young
children and the chitdren exposed to the
BPA are worrying ["the NTP has some
concern" l.
The effects on mammary gland and the
development of an earty puberty. in the
fetus, infants and the chitdren exposed
to BPA, are stightty worrying {"minimal
concern ").
or the growth of the chitd are regarded as
negtigibte {"negtigibte concern").
The effects of BPA on the reproduction
are regarded as negtigibte ["negtigibte
concern") for the non occupâtlonatly ex-
posédèdùtts and not very worrying {"mi-
nimaI concern") for the professionatty ex-
posed adutt INTP-CERHR, 2008j.
Opinion on BPA ol the Food and 0rgani'
zation Agriculture [FAol and the World
H ea lth 0 rga nization lW H 0 I
A joint FAOÀVHO expert meeting was or-
ganized in Ottawa, Canada, from 1 to 5
November 201 0, in order 1o review toxico-
togical and heatth aspects of bisphenot A.
Even if, at that time, we coutd read in the
media [Le Soir,1211112010) that fottowing
that meeting, the WH0 considered that
it was too early to ban bisphenol A from
baby feeding botttes, the summary re-
port of the meetrng [WHO, 2018] ctearty
"identified a number of gaps in knowledge
and provided a range of recommendations
for the generation of further information
and the design of new studies to better un'
derstand the risk to human heaLth posed by
BPA'.
Apinion on BPA of the Belgian Superior
Health Council
Recentty, to answer a question from the
Minister of Public Heatth, the Betgian Su-
perior Heatth CounciI recommended the
decrease, to a tevet as low as possibte of
the exposure of young chitdren to BPÀ
ISHC, 20101, on the basis of uncertainties
about toxic effects of BPA, in particular to
low doses.
c0NcLustoNs
The questions here below seem to remain
strtt without answers.
What about the effects of Low doses af BPA?
Ctassica[ty, the toxic effects retated to
a chemical substance fottow to a Iinear
dose-response curve.
It is not the same for substances acting
on receptors lsuch as the endocrine
disruptors) because the receptors can
be actrvated with low doses and inhibited
with stronger concentrations. ln these
cases, the dose-response curves appear
"bett-shaped" instead of [inear. Such ef-
fects with low doses were described for
BPA, but in studies disptaying certain
weaknesses which do not altow to va[i-
date the resutts in order to re-examine
downwards the TDI IEFSA, 2010J.
Which aLternatives to BPA in plastic ma-
teriaI are intended to come in contact with
food?
A tot "BPA free" baby feeding bottles are
atready found on the European market,
even if the BPA banishment is not yet in
The potycarbonate botttes can be replaced
by sulfonic potyether or potypropytene
botttes. ln its recent opinion {BfR, 2010),
BfR pointed out that the potypropytene
can release more substances in the food
than potycarbonate, and that the toxicity
of sulfonic potyether was less studied
than that of BPA. The best a[ternative thus
remains the gtass baby feeding bottte.
What about the other ways of exposure to
BPA than materials in contact with food?
Other ways of exposure [e.9. toys and
other objects in potycarbonate or PVCI
represent a considerabte source of ex-
posure to the BPA. This remark is atso
stressed in the study of Geens etal. [2010),
who have shown that the urinary concen-
tration of BPA in human is not completety
explained by the exposure through BPA
containing food consumption, suggesting
that other way of exposure are not negti-
gible. A recent study showed for example
the possible absorption of BPA from a
dermal exposure {Zatko et al., 2010). This
derma[ exposure could occur through for
exampte thermal paper coated with bis-
phenot A used for store receipts [Bieder-
man eta1.,2010).
It is clear that further research is needed
to ctarify the effects on heatth of bisphe-
nol A, as wetl as to asses the safety of
atternatives of BPA in ptastic materia[s
intended to come in contact with food.
It is rmportant, in particular, to c[artfy the
effects of [ow doses of BPA and to deter-
mine the best approach for risk assess-
ment {TDl or margin of exposurel.
Finatty, the other ways of exposure to
BPA than food consumption shou[d be in-
vestigated, knowing that onty 3 % of the
potycarbonate is used in plastic materiat
intended to come in contact with food
{Ptastics Ëurope, 2007).
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